CrushSCI.com
提供学术论文选刊润色服务
Experimental Hematology & Oncology 期刊封面 医学
返回期刊列表

Review Cycle Records

Experimental Hematology & Oncology

Springer SCIE OA
2026新锐 1区2025中科院 2区2025 JCR Q1
136.2平均天数
131.5中位天数
61最短天数
235最长天数
1412025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

186 天

Dysregulated KMT2D mutant targeting immunogenic rewiring to overcome epigenetic entropy promotes follicular lymphomagenesis

作者Yuqian Zhu; Jingwei Yao; Yuelong Jiang; Qian Lai; Qinwei Chen; Jingxing Zhang; Manman Deng; Zhijuan Lin; Yiming Luo; Zhifeng Li; Long Liu; Zhong Zheng; Jie Zha; Bing Xu

作者单位1. Department of Hematology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China; 2. Key Laboratory of Xiamen for Diagnosis and Treatment of Hematological Malignancy, Xiamen, China; 3. Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

PDF源文件 DOI 网页
199 天

Multimodal AI and single-cell transcriptomics integrate to construct a histopathological prognostic model for bladder cancer, revealing the RTN3-glycolysis axis in chemoresistance

作者Shunli Yu; Yingjian Wang; Dapeng Feng; Xinglai Dai; Yongbo Luo; Jianing Wang; Zihe Wang; Fuxiang Chen; Haoran Wang; Fengyan Tian; Xuejia Zhai; Chaohui Gu

作者单位1. Department of Urology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 2. Department of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 3. Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China; 4. Department of Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China

PDF源文件 DOI 网页
211 天

Combination of PARPi and topoisomerase I inhibitors is highly effective in olaparib-resistant ovarian cancer

作者M. Chiappa; V. Villa; F. Sias; C. Grasselli; L. Sala; S. Canesi; M. Marabese; S. Mason; D. Dibitetto; R. Fruscio; G. Damia

作者单位1. Laboratory of Preclinical Gynecological Oncology, Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; 2. Gynaecology Oncology Unit, Humanitas San Pio X, Milan, Italy; 3. Department of Biomedical Sciences, University of Sassari, Sassari, Italy; 4. Immunopharmacology Unit, Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; 5. Mouse & Animal Pathology Laboratory (MAPLab), Department of Veterinary Medicine and Animal Sciences, Fondazione UniMi, University of Milano, Lodi, Italy; 6. Laboratory of Molecular Pharmacology, Department of Experimental Oncology, Istituto Di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; 7. Molecular Oncology & DNA Damage Response Unit, Department of Experimental Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; 8. UO Gynecology, Department of Medicine and Surgery, Fondazione IRCCS San Gerardo dei Tintori, University of Milan-Bicocca, Monza, Italy

PDF源文件 DOI 网页
113 天

CD84 expression stratifies venetoclax response and reveals a targetable vulnerability in resistant acute myeloid leukemia

作者Xuemei Wang; Xiangjie Lin; Tianyi Chen; Yi Chen; Huafeng Wang; Yinghui Zhu

作者单位1. State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, China; 2. Frontier Science Center for Stem Cell Research, Tongji University, Shanghai, China; 3. Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China; 4. Zhejiang Key Laboratory for Precision Diagnosis and Treatment of Hematological Malignancies, Hangzhou, PR China; 5. Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China

PDF源文件 DOI 网页
153 天

Tumor-intrinsic NSUN2 orchestrates immunosuppression in lung adenocarcinoma via the m 5 C-HDAC8-CCL5 axis

作者Wangyang Meng; Tong Lu; Mingyuan Du; Xin Dai; Yichao Han; Yingyi Li; Haimin Xu; Biaolong Yang; Zeyu Wang; Hailei Du; Keman Liao; Xinnan Liu; Yidan Sun; Cui Yang; Dong Dong; Yan Yan; Wei Guo; Bin Li; Hecheng Li

作者单位1. Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 2. Center for Immune-Related Diseases, Shanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 3. Institute of Respiratory Diseases, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 4. Clinical Trial Ward, Shanghai Sixth People’s Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 5. Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 6. Department of Medical Oncology, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China; 7. Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China; 8. Department of Radiation Oncology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 9. Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

PDF源文件 DOI 网页
193 天

Chimeric antigen receptor (CAR)-T cell therapy for solid tumors in pediatric patients: current breakthroughs, dilemmas, and strategies

作者Yumiao Mai; Ziwen Wang; Juan Wang; Mengjia Song; Tong Xiang; Yuelin He; Alex H. Chang; Yizhuo Zhang

作者单位1. Department of Pediatric Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China; 2. State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China; 3. Department of Biotherapy, Sun Yat-sen University Cancer Center, Guangzhou, China; 4. Nanfang-Chunfu Children’s Institute of Hematology and Oncology, TaiXin Hospital, Dongguan, China; 5. Engineering Research Center of Gene Technology, Ministry of Education, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, China; 6. YaKe Center for Cell Engineering and Therapeutics, Shanghai, China

PDF源文件 DOI 网页
82 天

Clinical outcomes and molecular features of CEBPA -mutated MPAL: a multi-center case series

作者Yirong Wu; Weijie Luo; Na An; Xiaohan Zhang; Jianyun Li; Yixuan Cao; Yunxin Zeng; Peng Ke; Lu Liu; Linlin Yang; Changru Luo; Shiyu Chen; Sitian Yang; Haoyu Peng; Xiaoqing Li; Jingchao Fan; Rujiao Dong; Bingbing Wen; Xin Du; Lixin Wang; Guangyang Weng

作者单位1. Department of Hematology and Shenzhen Bone Marrow Transplantation Public Service Platform, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen, China; 2. Shenzhen Institute of Hematology, Shenzhen Second People’s Hospital, Shenzhen University Health Sciences Center, The First Affiliated Hospital of Shenzhen University, Shenzhen, China; 3. Hematology Department, People’s Hospital of Shenzhen Bao an District, Shenzhen, China; 4. Department of Hematology, Shenzhen People’s Hospital, Shenzhen, China; 5. Department of Hematology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China; 6. Department of Hematology and Oncology, Hematology Institution, Base for International Science and Technology Cooperation, Carson Cancer Stem Cell Vaccines R&D Center, International Cancer Center, Shenzhen University General Hospital, International Cancer Center, Haoshi Cell Therapy Institute of Shenzhen University, Shenzhen University Medical School, Shenzhen University, Shenzhen, China

PDF源文件 DOI 网页
105 天

Single-cell mapping of thymus-dependent naïve t-cell regeneration reveals CD61-associated states after hematopoietic stem cell transplantation

作者Fangqing Zhang; Xinya Jiang; Shuang Fan; Bixia Wang; Zhigui Wu; Jingrui Zhou; Qi Zhang; Zhiyu Zhang; Jianing Tang; Zheng-Li Xu; Yu Wang; Xiao-Jun Huang; Huidong Guo

作者单位1. Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Collaborative Innovation Center of Hematology, National Clinical Research Center for Hematologic Disease, Peking University People’s Hospital, Peking University Institute of Hematology, Peking University, Beijing, China; 2. Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China

PDF源文件 DOI 网页
105 天

Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025

作者Yujing Liang; Xinyi Deng; Ziwen Wang; Chuanmiao Xie; Lie Zheng; He Huang; Shaohan Yin; Huageng Huang

作者单位1. Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China; 2. Department of Dermatology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, P.R. China; 3. Department of Pediatric Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China; 4. Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China

PDF源文件 DOI 网页
235 天

Spatial multi omic profiling maps hypoxia-driven pro-fibrotic SPP1 + macrophages underpinning immune escape and TACE resistance in hepatocellular carcinoma

作者Fansen Ji; Hao Chen; Boyang Wu; Ying Xiao; Jiawei Zhang; Jianghui Yang; Weihua Yan; Xiaojuan Wang; Bingjun Tang; Huan Li; Siyu Wu; Quan He; Hao Liu; Haoming Xia; Xinquan Liu; Yibo Gao; Pengfei Wang; Shizhong Yang; Jiahong Dong

作者单位1. Tsinghua-Peking Center for Life Sciences, Beijing, China; 2. Hepatopancreatobiliary Center, Key Laboratory of Digital Intelligence Hepatology (Ministry of Education), School of Clinical Medicine, Tsinghua Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China; 3. Department of Pathology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China; 4. Health Management Center, Beijing Jishuitan Hospital, Capital Medical University, Beijing, China; 5. Cold Spring Biotech Corp., Beijing, China; 6. Institute for Organ Transplant and Bionic Medicine, Beijing Key Laboratory of Liver Transplantation and Bionic Manufacturing, Tsinghua University, Beijing, China; 7. Central Laboratory and Shenzhen Key Laboratory of Epigenetics and Precision Medicine for Cancers, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital and Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。